Patent · US Active

Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages

US8802433B2 · kind B2 · utility

1Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 3, 2010
Grant dateAug 12, 2014
Priority date
Expiry dateDec 3, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/645
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a highly effective macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages using an active component derived from natural products. A culture obtained by culturing microorganisms belonging to the genus Aureobasidium (Aureobasidium sp.) is used as the active component of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages. By means of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages, macrophage phagocytosis can be activated, and cytokine production in macrophages can be promoted. In particular, a macrophage phagocytosis-activating composition can activate the phagocytosis of cancer cells or cells damaged or destroyed by anticancer drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.